EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

The dual role of SGLT2 inhibitors: glycemic control and cardioprotection in anthracycline-treated cancer patients

Azad Mojahedi

International Journal of Physiology, Pathophysiology and Pharmacology · 2025

DOI: 10.62347/gaxz3059 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Physiology, Pathophysiology and Pharmacology, 2025. Verfasst von Azad Mojahedi. Beteiligte Einrichtung: Department of Internal Medicine, Stony Brook University Hospital New York, United States. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Heart failureanthracyclinescardiotoxicitysodium-glucose co-transporter-2 inhibitors

Autor:innen und Institutionen

  • Department of Internal Medicine, Stony Brook University Hospital New York, United States.

Zitieren

APA

Mojahedi, A. (2025). The dual role of SGLT2 inhibitors: glycemic control and cardioprotection in anthracycline-treated cancer patients. International Journal of Physiology, Pathophysiology and Pharmacology. https://doi.org/10.62347/gaxz3059

Vancouver

Mojahedi A. The dual role of SGLT2 inhibitors: glycemic control and cardioprotection in anthracycline-treated cancer patients. International Journal of Physiology, Pathophysiology and Pharmacology. 2025. doi:10.62347/gaxz3059

BibTeX
@article{Mojahedi2025,
  author = {Mojahedi, Azad},
  title = {The dual role of SGLT2 inhibitors: glycemic control and cardioprotection in anthracycline-treated cancer patients},
  journal = {International Journal of Physiology, Pathophysiology and Pharmacology},
  year = {2025},
  doi = {10.62347/gaxz3059}
}
Kostenlos starten →